Shmagin Martin E 4
4 · Urigen Pharmaceuticals, Inc. · Filed Jan 26, 2009
Insider Transaction Report
Form 4
Urigen Pharmaceuticals, Inc.UGRP.OB
Shmagin Martin E
DirectorChief Financial Officer
Transactions
- Purchase
Common Stock, $.001 Par Value
2009-01-22$0.14/sh−20,000$2,700→ 3,074,073 total - Purchase
Common Stock, $.001 Par Value
2009-01-23$0.16/sh−20,000$3,200→ 3,094,073 total